[1]
P. Chaturvedi and S. R. Shah, “Assessing the Clinical Outcomes of Voxelotor Treatment in Patients with Sickle Cell Disease”, Int J Appl Sci Biotechnol, vol. 12, no. 1, pp. 46–53, Mar. 2024.